Around 5% of healthy adults exposed to cannabidiol show elevated liver enzyme levels exceeding the normal threshold alongside ...

The global cannabidiol market size was US$ 5.1 billion in 2021. The global cannabidiol market is expected to grow to US$ 18.1 billion by 2030 by registering a compound annual growth rate (CAGR) of ...

A mom who almost lost her job for failing a drug test after taking "THC free" CBD gummies is campaigning for mandatory ...

Adolescent vaping of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids increased significantly from 2021 to 2023.

Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels.

FDA researchers report that the upper end of reported consumer use (~400mg of daily CBD intake) of cannabidiol (CBD) may ...

Fragile X disorders include two distinct conditions: fragile X syndrome (the most common single-gene cause of developmental delay and autism) and an entirely separate group of premutation syndromes.

It marked the third consecutive year that a regulatory bill failed, the latest front in a legislative fight that largely pits ...

An advert by Trip drinks has been banned for making unauthorised claims it can "help you feel calm". The ad for the drink, ...

As more and more people receive medicinal cannabis prescriptions, we’re left with a system that is misaligned with its ...

An FDA-funded clinical trial found even modest CBD use triggered elevated liver enzymes in some healthy adults, raising ...

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) is one of the 7 most undervalued pot stocks to buy according to analysts.